balofloxacin has been researched along with levofloxacin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kawahara, S; Nagare, H; Tada, A | 1 |
| Guo, C; Han, S; Jiang, H; Liu, T; Wu, X | 1 |
| Alqasim, A; Alyousef, AA; Arshad, M; Baker, A; Khalid, M; Khan, MS; Syed, A | 1 |
3 other study(ies) available for balofloxacin and levofloxacin
| Article | Year |
|---|---|
[In vitro antimycobacterial activities of a new quinolone, balofloxacin].
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Humans; Levofloxacin; Mycobacterium; Ofloxacin | 2001 |
In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Sericin-functionalized GNPs potentiate the synergistic effect of levofloxacin and balofloxacin against MDR bacteria.
Topics: Anti-Bacterial Agents; Escherichia coli; Fluoroquinolones; Gold; Levofloxacin; Metal Nanoparticles; Microbial Sensitivity Tests; Sericins; Staphylococcus aureus | 2020 |